We are developing Staccato™ Alprazolam for the treatment of Panic attacks associated with
panic disorder. This study will provide an initial assessment of efficacy, and to continue to
describe the tolerability and pharmacokinetics, of a single inhaled dose of Staccato
Alprazolam on a doxapram-induced panic attack in patients with panic disorder.